Bangkok Dusit Medical Services Public Company Limited (BDUUY)
- Previous Close
31.21 - Open
31.94 - Bid --
- Ask --
- Day's Range
31.94 - 31.94 - 52 Week Range
30.15 - 32.49 - Volume
102 - Avg. Volume
4 - Market Cap (intraday)
12.69B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
31.31 - EPS (TTM)
1.02 - Earnings Date Aug 13, 2024
- Forward Dividend & Yield 0.76 (2.37%)
- Ex-Dividend Date Mar 6, 2024
- 1y Target Est
--
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group names. It also offers laboratory, clinic, holistic clinical wellness, accounting, technology and information, training, investment and asset management, air transportation, skin and aesthetics telemedicine, and whole genome sequencing services; operates hotels; provides health insurance and insurance brokerage services; and distributes health products, cosmetic products, and facility management. In addition, the company is involved in production and distribution of medicines and pharmaceutical products; real estate; e-commerce; and investment and operation of BDMS silver wellness and residence products. Bangkok Dusit Medical Services Public Company Limited was founded in 1969 and is based in Bangkok, Thailand.
www.bdms.co.th--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BDUUY
Performance Overview: BDUUY
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BDUUY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BDUUY
Valuation Measures
Market Cap
11.96B
Enterprise Value
12.06B
Trailing P/E
31.31
Forward P/E
28.57
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.52
Price/Book (mrq)
4.69
Enterprise Value/Revenue
4.30
Enterprise Value/EBITDA
17.21
Financial Highlights
Profitability and Income Statement
Profit Margin
14.31%
Return on Assets (ttm)
8.39%
Return on Equity (ttm)
15.53%
Revenue (ttm)
104.73B
Net Income Avi to Common (ttm)
14.98B
Diluted EPS (ttm)
1.02
Balance Sheet and Cash Flow
Total Cash (mrq)
13.02B
Total Debt/Equity (mrq)
16.13%
Levered Free Cash Flow (ttm)
8.77B